KELES

KELES is a pioneering European venture capital firm focused on accelerating innovation in digital health and life sciences. It targets growth-stage companies leveraging AI for drug discovery, precision diagnostics, and next-generation patient care solutions. The firm integrates ESG principles into its investment strategy—certified under SFDR Article 9 by PwC—and aims to deliver both financial returns and measurable social impact by improving healthcare accessibility and outcomes across Europe. Founded by industry veterans from pharma, techbio, venture capital, and financial management backgrounds—including ex-CSO Sanofi Laurent Van Lerberghe—the team provides strategic guidance alongside capital to scale transformative technologies globally.